Patient Reported Outcomes Following Percutaneous Lung Ablation

Study summary

This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNon-Interventional Study

The study team can explain what participation involves.

Who it may be forLung Neoplasm

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 22, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Not Yet Recruiting

The study is not accepting participants yet.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Mayo Clinic

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Mayo Clinic
Interventions being studied: Other: Non-Interventional Study

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Undergoing percutaneous lung ablation

Reasons someone may not be able to joinExclusion criteria

Decline to participate in research

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mayo Clinic in RochesterRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 22, 2026. Always confirm current availability with the study team.

View original record ↗